SCHEMBL30692438

SCHEMBL30692438

CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TASP1 Q9H6P5 1/20 0.49
▸ VIPR1 P32241 3/20 0.47
▸ NPY2R P49146 7/20 0.46
▸ NPY4R P50391 7/20 0.46
▸ NPY5R Q15761 7/20 0.46
▸ NPY1R P25929 5/20 0.46
▸ TFPI P10646 1/20 0.46
▸ GRIN2D O15399 1/20 0.44
▸ GRIN3B O60391 1/20 0.44
▸ GRIN1 Q05586 1/20 0.44
▸ GRIN2A Q12879 1/20 0.44
▸ GRIN2B Q13224 1/20 0.44
▸ GRIN2C Q14957 1/20 0.44
▸ GRIN3A Q8TCU5 1/20 0.44
▸ VIPR2 P41587 3/20 0.43
▸ GLP1R P43220 2/20 0.43
▸ ECE1 P42892 1/20 0.43
▸ MUS81 Q96NY9 1/20 0.43
▸ KISS1R Q969F8 2/20 0.43
▸ RXFP1 Q9HBX9 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29416160 0.96 TASP1 (0.49) TASP1VIPR1NPY2RNPY4RNPY5R
SCHEMBL29805066 0.94 GRIN2D (0.52) TASP1VIPR1NPY2RNPY4RNPY5R
SCHEMBL29424990 0.94 VIPR1 (0.52) TASP1VIPR1NPY2RNPY4RNPY5R
SCHEMBL31168167 0.92 ENPEP (0.48) TASP1VIPR1NPY2RNPY4RNPY5R
SCHEMBL29416066 0.92 GRIN2D (0.52) VIPR1NPY2RNPY4RNPY5RNPY1R
SCHEMBL29468197 0.90 VIPR1 (0.50) TASP1VIPR1NPY2RNPY4RNPY5R
Fexapotide SCHEMBL29356097 0.90 VIPR1 (0.50) TASP1VIPR1NPY2RNPY4RNPY5R
SCHEMBL30680476 0.90 ENPEP (0.46) VIPR1NPY2RNPY4RNPY5RNPY1R
SCHEMBL30692435 0.89 TFPI (0.47) TASP1VIPR1NPY2RNPY4RNPY5R
SCHEMBL30381394 0.88 TASP1 (0.49) TASP1VIPR1NPY2RNPY4RNPY5R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240252516-A1 COMBINATION BPH THERAPY WITH FEXAPOTIDE TRIFLUTATE, A 5-ARI, AND AN ALPHA BLOCKER NYMOX CORPORATION 2024-08-01 — — US disclosed
CN-110381984-B Compositions and methods for improving sexual function 尼莫克斯股份有限公司 2023-11-28 — — CN disclosed
Send feedback